Preclinical to clinical utility of ROCK inhibitors in cancer

被引：45
作者：
Barcelo, Jaume [1 ]
Samain, Remi [1 ]
Sanz-Moreno, Victoria [1 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
TRENDS IN CANCER | 2023年 / 9卷 / 03期
关键词：
RHO KINASE INHIBITORS; ACTOMYOSIN CONTRACTILITY; SOMATIC MUTATIONS; CELL-MIGRATION; INVASION; ACTIVATION; PHOSPHORYLATION; PROGRESSION; MECHANISMS; CARCINOMA;
D O I：
10.1016/j.trecan.2022.12.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ROCK belongs to the AGC family of Ser/Thr protein kinases that are involved in many cellular processes. ROCK-driven actomyosin contractility regulates cyto-skeletal dynamics underpinning cell migration, proliferation, and survival in many cancer types. ROCK1/2 play key protumorigenic roles in several subtypes and stages of cancer development. Therefore, successfully targeting ROCK and its downstream effectors presents an interesting avenue for cancer treatment. Because local use of ROCK inhibitors will reduce the side effects of systemic administration, we propose different therapeutic strategies and latest-generation ROCK inhibitors for use in the clinic.
引用
收藏
页码：250 / 263
页数：14
相关论文
共 94 条
  • [1] Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma
    Abe, Hideyuki
    Kamai, Takao
    Tsujii, Toshihiko
    Nakamura, Fumihiko
    Mashidori, Tomoko
    Mizuno, Tomoya
    Tanaka, Miho
    Tatsumiya, Katsuhisa
    Furuya, Nobutaka
    Masuda, Akinori
    Yamanishi, Tomonori
    Yoshida, Ken-Ichiro
    [J]. BIOMEDICAL RESEARCH-TOKYO, 2008, 29 (03): : 155 - 161
  • [2] Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects
    Al-Hilal, Taslim A.
    Hossain, Mohammad Anwar
    Alobaida, Ahmed
    Alam, Farzana
    Keshavarz, Ali
    Nozik-Grayck, Eva
    Stenmark, Kurt R.
    German, Nadezhda A.
    Ahsan, Fakhrul
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 334 : 237 - 247
  • [3] Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity
    Amano, Mutsuki
    Nakayama, Masanori
    Kaibuchi, Kozo
    [J]. CYTOSKELETON, 2010, 67 (09) : 545 - 554
  • [4] Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
    Anastassiadis, Theonie
    Deacon, Sean W.
    Devarajan, Karthik
    Ma, Haiching
    Peterson, Jeffrey R.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (11) : 1039 - U117
  • [5] Comprehensive molecular characterization of gastric adenocarcinoma
    Bass, Adam J.
    Thorsson, Vesteinn
    Shmulevich, Ilya
    Reynolds, Sheila M.
    Miller, Michael
    Bernard, Brady
    Hinoue, Toshinori
    Laird, Peter W.
    Curtis, Christina
    Shen, Hui
    Weisenberger, Daniel J.
    Schultz, Nikolaus
    Shen, Ronglai
    Weinhold, Nils
    Keiser, David P.
    Bowlby, Reanne
    Sipahimalani, Payal
    Cherniack, Andrew D.
    Getz, Gad
    Liu, Yingchun
    Noble, Michael S.
    Pedamallu, Chandra
    Sougnez, Carrie
    Taylor-Weiner, Amaro
    Akbani, Rehan
    Lee, Ju-Seog
    Liu, Wenbin
    Mills, Gordon B.
    Yang, Da
    Zhang, Wei
    Pantazi, Angeliki
    Parfenov, Michael
    Gulley, Margaret
    Piazuelo, M. Blanca
    Schneider, Barbara G.
    Kim, Jihun
    Boussioutas, Alex
    Sheth, Margi
    Demchok, John A.
    Rabkin, Charles S.
    Willis, Joseph E.
    Ng, Sam
    Garman, Katherine
    Beer, David G.
    Pennathur, Arjun
    Raphael, Benjamin J.
    Wu, Hsin-Ta
    Odze, Robert
    Kim, Hark K.
    Bowen, Jay
    [J]. NATURE, 2014, 513 (7517) : 202 - 209
  • [6] Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors
    Boland, Sandro
    Bourin, Arnaud
    Alen, Jo
    Geraets, Jacques
    Schroeders, Pieter
    Castermans, Karolien
    Kindt, Nele
    Boumans, Nicki
    Panitti, Laura
    Fransen, Silke
    Vanormelingen, Jessica
    Stassen, Jean Marie
    Leysen, Dirk
    Defert, Olivier
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (10) : 4309 - 4324
  • [7] Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
    Calvo, Fernando
    Ege, Nil
    Grande-Garcia, Araceli
    Hooper, Steven
    Jenkins, Robert P.
    Chaudhry, Shahid I.
    Harrington, Kevin
    Williamson, Peter
    Moeendarbary, Emad
    Charras, Guillaume
    Sahai, Erik
    [J]. NATURE CELL BIOLOGY, 2013, 15 (06) : 637 - +
  • [8] RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation
    Calvo, Fernando
    Sanz-Moreno, Victoria
    Agudo-Ibanez, Lorena
    Wallberg, Fredrik
    Sahai, Erik
    Marshall, Christopher J.
    Crespo, Piero
    [J]. NATURE CELL BIOLOGY, 2011, 13 (07) : 819 - U204
  • [9] Δ133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling
    Campbell, Hamish
    Fleming, Nicholas
    Roth, Imogen
    Mehta, Sunali
    Wiles, Anna
    Williams, Gail
    Vennin, Claire
    Arsic, Nikola
    Parkin, Ashleigh
    Pajic, Marina
    Munro, Fran
    McNoe, Les
    Black, Michael
    McCall, John
    Slatter, Tania L.
    Timpson, Paul
    Reddel, Roger
    Roux, Pierre
    Print, Cristin
    Baird, Margaret A.
    Braithwaite, Antony W.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [10] TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination
    Cantelli, Gala
    Orgaz, Jose L.
    Rodriguez-Hernandez, Irene
    Karagiannis, Panagiotis
    Maiques, Oscar
    Matias-Guiu, Xavier
    Nestle, Frank O.
    Marti, Rosa M.
    Karagiannis, Sophia N.
    Sanz-Moreno, Victoria
    [J]. CURRENT BIOLOGY, 2015, 25 (22) : 2899 - 2914
12345678910